PD27-12 PRIMARY ANALYSIS OF IMVIGOR 210: ATEZOLIZUMAB IN PLATINUM-TREATED ADVANCED UROTHELIAL CARCINOMA
Author(s) -
Robert Dreicer,
Michiel S. van der Heijden,
Petros Grivas,
Jean H. Hoffman-Censits,
Yohann Loriot,
Margitta Retz,
Nicholas J. Vogelzang,
Jose Luis PérezGracia,
Arash Rezazadeh Kalebasty,
Sergio Bracarda,
Evan Y. Yu,
Christopher Hoimes,
Joaquim Bellmunt,
David I. Quinn,
Daniel P. Petrylak,
Syed Afroze Hussain,
Na Cui,
Sanjeev Mariathasan,
Fatema A. Legrand,
Jonathan E. Rosenberg
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.386
Subject(s) - medicine , urothelial carcinoma , classics , atezolizumab , theology , library science , philosophy , cancer , history , bladder cancer , immunotherapy , pembrolizumab , computer science
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom